Ampel Therapeutics

Ampel Therapeutics is a precision medicine company focused on immunology and inflammation, utilizing a proprietary genomic platform and artificial intelligence to transform patient care. The company's technology analyzes RNA expression data to characterize the immune system's state, allowing for personalized treatment selection and disease monitoring. Their lead product, LuGENE, is a blood-based diagnostic test designed to predict flares and identify optimal therapies for patients with Systemic Lupus Erythematosus (SLE). Ampel also collaborates with pharmaceutical partners to rescue failed clinical trials and accelerate drug development by identifying responsive patient subpopulations. Headquartered in Charlottesville, Virginia, the company was founded by world-renowned experts in rheumatology and bioinformatics.